RMGP Biopharma Investment Fund

Venture Capital New York, United States Est. 2017
Visit website ↗
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—

About

The RMGP Biopharma Investment Fund represents an opportunity to invest alongside industry leaders in innovative early-stage biotherapeutics through a dedicated platform. RMGP and its partners identified innovative early-stage biopharmaceutical assets as a highly attractive investment opportunity. The fund invests in early-stage biopharmaceutical solutions alongside industry leaders such as OrbiMed, J&J, and Takeda. The fund is dedicated to FutuRx's portfolio of first-in-class and best-in-class assets, and it invests exclusively in companies operating in Israel's FutuRx incubator. Based on RM Global's core investment banking capabilities, the fund will provide its portfolio companies with strategic and business development support to maximize potential return.

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is the primary investment focus of RMGP Biopharma Investment Fund?
RMGP Biopharma Investment Fund primarily invests in innovative early-stage biotherapeutics, specifically in biopharmaceutical solutions.
When was RMGP Biopharma Investment Fund founded?
RMGP Biopharma Investment Fund was founded in 2017.
What is the geographic focus for RMGP Biopharma Investment Fund's investments?
RMGP Biopharma Investment Fund invests exclusively in companies operating in Israel's FutuRx incubator.
Which notable industry leaders does RMGP Biopharma Investment Fund invest alongside?
RMGP Biopharma Investment Fund invests alongside industry leaders such as OrbiMed, J&J, and Takeda.
What are some of the most significant investments made by RMGP Biopharma Investment Fund by amount?
RMGP Biopharma Investment Fund made a $111 million investment in ImmPACT Bio in January 2022 and a $32 million investment in BiomX in February 2019.
Has RMGP Biopharma Investment Fund experienced any exits from its portfolio companies?
Yes, RMGP Biopharma Investment Fund has had two exits: ImmPACT Bio was acquired by Lyell Immunopharma in October 2024, and BiomX underwent a Reverse Merger Event in November 2019.
What is the total number of portfolio companies for RMGP Biopharma Investment Fund according to startupim data?
RMGP Biopharma Investment Fund has 16 portfolio companies listed in startupim data.
What is the range of investment amounts for RMGP Biopharma Investment Fund?
RMGP Biopharma Investment Fund's investment range is between $3 million and $111 million.
What kind of support does RMGP Biopharma Investment Fund provide to its portfolio companies?
Based on RM Global's core investment banking capabilities, RMGP Biopharma Investment Fund provides strategic and business development support to its portfolio companies.